ES485105A1 - Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno - Google Patents

Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno

Info

Publication number
ES485105A1
ES485105A1 ES485105A ES485105A ES485105A1 ES 485105 A1 ES485105 A1 ES 485105A1 ES 485105 A ES485105 A ES 485105A ES 485105 A ES485105 A ES 485105A ES 485105 A1 ES485105 A1 ES 485105A1
Authority
ES
Spain
Prior art keywords
adeno
newcastle disease
viruses
active against
drop caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES485105A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES485105A1 publication Critical patent/ES485105A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10111—Atadenovirus, e.g. ovine adenovirus D
    • C12N2710/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Procedimiento para la preparación de un líquido inicial que contiene virus de tipo adeno, para la preparación de una vacuna inactivada combinada dispuesta para administración, caracterizado porque un virus de tipo adeno se cultiva en huevos de pato o en un cultivo celular, tal como un cultivo en frascos rodantes de monocapa o un cultivo de células unidas a vehículos inertes sólidos, de fibroblastos de embrión de pato.
ES485105A 1978-09-14 1979-10-17 Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno Expired ES485105A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7809364 1978-09-14
NL7903300 1979-04-26

Publications (1)

Publication Number Publication Date
ES485105A1 true ES485105A1 (es) 1980-06-16

Family

ID=26645447

Family Applications (2)

Application Number Title Priority Date Filing Date
ES484187A Expired ES484187A1 (es) 1978-09-14 1979-09-14 Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno
ES485105A Expired ES485105A1 (es) 1978-09-14 1979-10-17 Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES484187A Expired ES484187A1 (es) 1978-09-14 1979-09-14 Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno

Country Status (10)

Country Link
US (1) US4537768A (es)
EP (1) EP0009277B1 (es)
DE (1) DE2966914D1 (es)
DK (1) DK157732C (es)
ES (2) ES484187A1 (es)
FR (1) FR2435949A1 (es)
GR (1) GR70272B (es)
IE (1) IE48482B1 (es)
LU (1) LU81687A1 (es)
PT (1) PT70156A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7812359A (nl) * 1978-12-20 1980-06-24 Gist Brocades Nv Vaccins tegen door reo virus veroorzaakte ziektever- schijnselen en werkwijze voor het bereiden van deze vaccins.
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
US5084271B1 (en) * 1984-09-11 1997-08-05 Univ Melbourne Vaccine for equine herpesvirus
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
FR2706665B1 (fr) * 1993-06-11 1995-09-08 Fis Dispositif pour la fixation d'un boîtier d'affichage électronique.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292949A (es) *
US3083142A (en) * 1958-02-27 1963-03-26 Glaxo Group Ltd Improved swine erysipelas vaccine
US3060094A (en) * 1959-04-07 1962-10-23 Ray M Dutcher Preparation of virus vaccines
US3149036A (en) * 1961-10-16 1964-09-15 Merck & Co Inc Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent
US3399263A (en) * 1965-04-12 1968-08-27 American Cyanamid Co Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
NL7012832A (es) * 1970-08-29 1972-03-02
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US3906092A (en) * 1971-11-26 1975-09-16 Merck & Co Inc Stimulation of antibody response
JPS529727B2 (es) * 1971-12-29 1977-03-18
JPS506714A (es) * 1973-05-31 1975-01-23
US3983228A (en) * 1973-08-28 1976-09-28 Merck & Co., Inc. Water-in-oil adjuvant composition
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
JPS529727A (en) * 1975-07-11 1977-01-25 Toyota Motor Corp Carburettor
GB1590448A (en) * 1977-03-04 1981-06-03 Akzo Nv Vaccine and its preparations

Also Published As

Publication number Publication date
EP0009277A1 (en) 1980-04-02
EP0009277B1 (en) 1984-04-18
FR2435949B1 (es) 1984-05-18
DK157732C (da) 1990-07-09
US4537768A (en) 1985-08-27
IE48482B1 (en) 1985-02-06
LU81687A1 (fr) 1981-04-17
GR70272B (es) 1982-09-03
DK383079A (da) 1980-03-15
DK157732B (da) 1990-02-12
IE791745L (en) 1980-03-14
PT70156A (en) 1979-10-01
FR2435949A1 (fr) 1980-04-11
ES484187A1 (es) 1980-04-01
DE2966914D1 (en) 1984-05-24

Similar Documents

Publication Publication Date Title
KR0162646B1 (ko) 보조제로서 토콜을 함유한 백신 및 그것의 제조방법
ES2052564T3 (es) Procedimiento para la produccion de acido bishomo-gamma-linolenico y acido eicosapanteonico.
BR9710394A (pt) Processo para preparação de ácido docosahexaenóico e ácido docosapentaenóico;processo de preparação a partir de lipidio;microorganismo produtor de lipìdios;alimentos e congenêres abtidos através do processo
BR9510223A (pt) Adjuvante para vacinas utilização de um polissacarideo lipidico processo para preparar uma cacina em emulsão e vacina
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
DE3473825D1 (en) Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
US3655871A (en) Inactivation of influenza viruses with lower alkyl esters of acetic acid
ES484187A1 (es) Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno
EP0101348A3 (en) Avian proventriculitis vaccine, avian proventriculitis reovirus, process for preparing said vaccine and method of protecting a poultry animal against proventriculitis
ES8105150A1 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
US4515777A (en) Vaccines
Mack et al. Serological response in chickens to beta-propiolactone treated Newcastle disease virus
EP0343548B1 (de) Antigenlösung ethaltend ein Polyalphaolefin (PAO), Verfahren ihrer Herstellung und die Verwendung von PAO als Adjuvans
JPS63126493A (ja) 抗ウイルス剤
JPS5656223A (en) Starch sugar ester
IE58822B1 (en) Biological preparations
GB586918A (en) Improvements relating to cartons for use as flower pots
NZ243251A (en) Vaccine against marek's disease virus in poultry
GB551246A (en) Improvements in or relating to sulphonated compounds
GB776644A (en) Preparations for the care of the human hair and scalp
ES2053402A1 (es) Metodo de preparacion de vacunas inactivadas y vacunas vivas adyuvantadas asi como las vacunas obtenidas por dicho metodo.
JPS5665817A (en) Vitamin k injection
JPS57167925A (en) Preparation of mixed vaccine for domestic fowl
JPS5692787A (en) Preparation of choline oxidase